Biopharmaceutical News Week # 3.2017
Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com Mergers, Acquisitions and Joint Ventures Eli Lilly acquires CoLucid (Cambridge, MA, USA) and increases its migraine pain management with lasmiditan in a deal worth $960 million. Lasmiditan has completed the first of two pivotal phase 3 trials, a second one is expected […]
read moreNeed Help for next business conventions ?
1-Outsourced preparation of your next business convention: You would like to take part to next Bio Business convention (Bio-Europe Spring, Bio-Europe, BIO-US, BIO-Asia or other Business conventions). But a good preparation for a business convention is time-consuming and you have more important task to do. You can outsource the meeting requests to focus only on the last […]
read moreBiopharmaceutical News Week # 2.2017
Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com Editor’s Note During a press conference on Wednesday, US President Elect Donald Trump promised to control drug prices in pledging aggressive federal bidding process. Some of the excerpt: “We have to get our drug industry coming back. Our drug industry has been disastrous. They […]
read moreBiopharma News Week1-2017
Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com Editor’s Note We wish all our subscribers and readers a Happy and Successful Year 2017 The year 2016 finished with an impressive scientific triumph that will change the way the medical community will fight the Ebola virus. An experimental Ebola vaccine named rVSV-ZEBOV, tested on humans in […]
read moreLast News
- Le déclassement de la France
- Une approche diagnostique holistique de la maladie d’Alzheimer.
- UK approves Kisunla for the treatment of Alzheimer’s disease but NICE …does not pay for it.
Events
News archives
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- March 2024
- February 2024
- January 2024
- November 2023
- September 2023
- July 2023
- April 2023
- March 2023
- January 2023
- December 2022
- November 2022
- October 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- October 2018
- June 2018
- May 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- September 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014
- November 2013
- September 2013
- July 2013
- May 2013
- April 2013
- March 2013
- January 2013
- December 2012
- November 2012
- October 2012
- March 2012